MENU
+Compare
XOMA
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$24.06
Change
+$0.72 (+3.08%)
Capitalization
276.71M

XOMA XOMA Royalty Corporation Forecast, Technical & Fundamental Analysis

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health... Show more

Industry: #Biotechnology
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for XOMA with price predictions
Apr 23, 2025

Momentum Indicator for XOMA turns positive, indicating new upward trend

XOMA saw its Momentum Indicator move above the 0 level on April 14, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 104 similar instances where the indicator turned positive. In of the 104 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for XOMA just turned positive on April 09, 2025. Looking at past instances where XOMA's MACD turned positive, the stock continued to rise in of 55 cases over the following month. The odds of a continued upward trend are .

XOMA moved above its 50-day moving average on April 21, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XOMA advanced for three days, in of 272 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XOMA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XOMA broke above its upper Bollinger Band on April 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for XOMA entered a downward trend on April 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.407) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.020) settles around the average of (0.025) among similar stocks. P/S Ratio (26.738) is also within normal values, averaging (252.992).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XOMA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XOMA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

XOMA is expected to report earnings to rise 624.25% to -28 cents per share on May 13

XOMA Royalty Corporation XOMA Stock Earnings Reports
Q1'25
Est.
$-0.29
Q4'24
Beat
by $0.25
Q3'24
Missed
by $1.15
Q2'24
Beat
by $1.10
Q1'24
Missed
by $0.22
The last earnings report on March 17 showed earnings per share of -3 cents, beating the estimate of -28 cents. With 2.92K shares outstanding, the current market capitalization sits at 276.71M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical preparations

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2200 Powell Street
Phone
+1 510 204-7200
Employees
13
Web
https://www.xoma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PUFCX17.83N/A
N/A
PGIM Jennison Financial Services C
PNOPX106.38N/A
N/A
Putnam Sustainable Leaders A
SPFCX15.55N/A
N/A
PGIM Jennison Focused Growth C
WWICX11.34N/A
N/A
Westwood Income Opportunity C
RPNCX9.15N/A
N/A
Riverpark/Next Century Growth Retail

XOMA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMA has been loosely correlated with CRBU. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if XOMA jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMA
1D Price
Change %
XOMA100%
+0.82%
CRBU - XOMA
37%
Loosely correlated
+0.79%
RCUS - XOMA
36%
Loosely correlated
+0.25%
ZNTL - XOMA
36%
Loosely correlated
+1.70%
LYEL - XOMA
36%
Loosely correlated
+3.91%
AVIR - XOMA
34%
Loosely correlated
-0.98%
More